A 52-year-old woman with Type II endometrial carcinoma (uterine serous carcinoma, FIGO Stage III) is completing surgical staging. Optimal surgical staging for uterine serous carcinoma requires which additional step beyond standard staging for Type I endometrial carcinoma?

• A Omentectomy and peritoneal biopsies — uterine serous carcinoma has exfoliative peritoneal spread similar to ovarian serous carcinoma ✓
• B Pelvic exenteration for best local control of serous histology
• C Sentinel lymph node biopsy replaces complete lymphadenectomy in serous histology for staging accuracy
• D PET-CT scan-based staging is sufficient without surgical lymph node sampling for serous carcinoma

Explanation

Uterine serous carcinoma (USC) behaves biologically like ovarian serous carcinoma — it spreads early via peritoneal exfoliation to the omentum and peritoneal surfaces, even when the tumor appears confined to the uterus on imaging. Therefore, surgical staging for USC must include omentectomy and systematic peritoneal biopsies (multiple sites including diaphragm, paracolic gutters, pelvic peritoneum) in addition to hysterectomy, BSO, and lymphadenectomy — staging performed for apparent early disease often reveals occult peritoneal metastases that upstage the patient. This 'comprehensive staging' for serous histology is not required for standard Type I (endometrioid) carcinoma. Exenteration (B) is primary treatment only for central recurrence. SLN alone (C) is being studied but not standard for serous histology in most guidelines.

Reference: Shaw's Textbook of Gynaecology, 17th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.